To include your compound in the COVID-19 Resource Center, submit it here.

Adeona, Meda deal

Adeona granted Meda exclusive rights to develop and commercialize flupirtine to treat fibromyalgia in the U.S., Canada and Japan, including an issued U.S. patent

Read the full 242 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE